A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors.
Nock CJ, Brell JM, Bokar JA, Cooney MM, Cooper B, Gibbons J, Krishnamurthi S, Manda S, Savvides P, Remick SC, Ivy P, Dowlati A.
Nock CJ, et al. Among authors: manda s.
Invest New Drugs. 2011 Feb;29(1):126-30. doi: 10.1007/s10637-009-9322-9. Epub 2009 Sep 23.
Invest New Drugs. 2011.
PMID: 19774342
Free PMC article.
Clinical Trial.